KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Thursday, 25th Apr 2024 AFMD stock ended at $4.88. During the day the stock fluctuated 7.81% from a day low at $4.61 to a day high of $4.97.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Sep 23, 2021 $64.00 $66.00 $63.50 $65.90 45 525
Sep 22, 2021 $64.10 $65.40 $63.40 $63.40 56 683
Sep 21, 2021 $63.40 $64.81 $62.80 $63.90 65 365
Sep 20, 2021 $62.40 $64.00 $62.00 $63.00 88 588
Sep 17, 2021 $64.10 $64.17 $61.45 $63.90 120 261
Sep 16, 2021 $63.40 $63.85 $60.70 $63.50 119 188
Sep 15, 2021 $64.50 $64.67 $62.35 $63.30 83 987
Sep 14, 2021 $64.10 $66.40 $63.30 $64.30 86 843
Sep 13, 2021 $65.10 $66.00 $62.25 $63.70 88 288
Sep 10, 2021 $67.00 $67.40 $64.25 $64.80 112 981
Sep 09, 2021 $67.50 $69.65 $66.30 $67.00 130 509
Sep 08, 2021 $68.80 $70.00 $62.00 $68.00 227 609
Sep 07, 2021 $66.78 $68.80 $66.50 $67.40 77 244
Sep 03, 2021 $71.00 $71.00 $66.60 $66.90 72 572
Sep 02, 2021 $71.60 $71.60 $68.80 $70.80 70 815
Sep 01, 2021 $70.70 $71.60 $69.99 $71.50 72 660
Aug 31, 2021 $70.60 $72.00 $68.70 $70.40 71 287
Aug 30, 2021 $72.30 $73.40 $70.20 $70.70 120 074
Aug 27, 2021 $68.00 $72.85 $67.90 $72.10 155 512
Aug 26, 2021 $66.10 $70.20 $65.90 $67.50 219 517
Aug 25, 2021 $61.60 $66.85 $61.00 $66.00 139 663
Aug 24, 2021 $62.20 $62.20 $59.80 $61.70 180 360
Aug 23, 2021 $60.00 $61.70 $58.70 $61.00 224 660
Aug 20, 2021 $55.00 $58.00 $54.30 $57.30 162 617
Aug 19, 2021 $57.41 $57.80 $55.20 $55.40 87 192
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT